文献速递炎症性肠病

III型胶原形成/降解失衡作为穿透型(蒙特利尔B3)克罗恩病的新型血清学生物标志物

Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-05-08

该回顾性单中心队列研究检测112例回肠末端克罗恩病患者及24例健康对照的血清胶原形成与降解标志物,发现穿透型患者C3M和Pro-C5水平升高,Pro-C3/C3M比值区分穿透型与非狭窄非穿透型及狭窄型的曲线下面积分别为0.815±0.109和0.746±0.114。

要点

  • 穿透型克罗恩病以基质金属蛋白酶-9降解的III型胶原增加和V型胶原形成增加为特征。
  • 活动性炎症以V型胶原形成增加及I、III型胶原基质金属蛋白酶介导的分解增加为特征。
  • Pro-C3/C3M比值区分穿透型与炎症型及狭窄型克罗恩病优于其他指标。

核心结论

  • 血清学生物标志物显示穿透型克罗恩病以基质金属蛋白酶-9降解的III型胶原增加和V型胶原形成增加为特征。
  • 活动性炎症以V型胶原形成增加及I、III型胶原基质金属蛋白酶介导的分解增加为特征。
  • Pro-C3/C3M比值在区分穿透型克罗恩病与炎症型及狭窄型克罗恩病方面更优。

研究设计与样本

  • 回顾性单中心队列研究,纳入112例回肠末端克罗恩病患者(非狭窄非穿透型n=40,狭窄型n=55,穿透型n=17)和24例健康对照。
  • 检测血清I、III、V、VI型胶原形成标志物(P1NP、Pro-C3、Pro-C5、Pro-C6)及基质金属蛋白酶介导的降解标志物(C1M、C3M、C5M、C6M)。
  • 活动性炎症定义为CRP>5 mg/L。

主要发现

  • 穿透型 vs 非狭窄非穿透型及狭窄型:C3M 33.6±5 vs 25.8±2.2 nmol/L(P=.004)和27.2±2.3 nmol/L(P=.018);Pro-C5 1262.7±259.4 vs 902.9±109.9 nmol/L(P=.005)和953.0±106.4 nmol/L(P=.015)。
  • 有活动性炎症 vs 无活动性炎症:C1M 71.2±26.1 vs 46.2±6.2 nmol/L(P<.001),C3M 31.6±3.9 vs 26.1±1.6 nmol/L(P=.002),Pro-C5 1171.7±171.5 vs 909.6±80.4 nmol/L(P=.002)。
  • Pro-C3/C3M比值区分穿透型 vs 非狭窄非穿透型及狭窄型的曲线下面积分别为0.815±0.109(P<.001)和0.746±0.114(P=.002)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Misbalances in extracellular matrix turnover are key factors in the development of stricturing (Montreal B2) and penetrating (Montreal B3) Crohn's disease. AIM: To determine whether serological markers for collagen formation and degradation could serve as biomarkers for complications of Crohn's disease. METHODS: Serum biomarkers for type I, III, V and VI collagen formation (P1NP, Pro-C3, Pro-C5, Pro-C6) and matrix metalloproteinase mediated degradation (C1M, C3M, C5M and C6M) were measured in a retrospective, single centre cohort of 112 patients with Crohn's disease in the terminal ileum (nonstricturing/nonpenetrating: n=40, stricturing: n=55, penetrating: n=17) and 24 healthy controls. Active inflammation was defined as CRP >5 mg/L. RESULTS: C3M and Pro-C5 levels were higher in penetrating vs nonpenetrating/nonstricturing and stricturing disease (33.6±5 vs 25.8±2.2 [P=.004] and 27.2±2.3 [P=.018] nmol/L C3M, 1262.7±259.4 vs 902.9±109.9 [P=.005] and 953.0±106.4 [P=.015] nmol/L Pro-C5). C1M (71.2±26.1 vs 46.2±6.2 nmol/L [P<.001]), C3M (31.6±3.9 vs 26.1±1.6 nmol/L [P=.002] and Pro-C5 levels (1171.7±171.5 vs 909.6±80.4 nmol/L [P=.002]) were higher in patients with active inflammation vs without active inflammation. Pro-C3/C3M-ratios were best to differentiate between penetrating vs nonstricturing/nonpenetrating and stricturing disease with area under the curves of 0.815±0.109 (P<.001) and 0.746±0.114 (P=.002) respectively. CONCLUSIONS: Serological biomarkers show that penetrating Crohn's disease is characterised by increased matrix metalloproteinase-9 degraded type III collagen and formation of type V collagen. Active inflammation in Crohn's disease is characterised by increased formation of type V collagen and increased matrix metalloproteinase mediated breakdown of type I, III collagen. Pro-C3/C3M ratios are superior in differentiating between penetrating Crohn's disease vs inflammatory and stricturing Crohn's disease.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. van Haaften WT, Mortensen JH, Karsdal MA, et al. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. Aliment Pharmacol Ther. 2017. PMID: 28481042. doi:10.1111/apt.14092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。